The electrophysiology catheter market in Europe is expected to grow from US$ 1,141.71 million in 2021 to US$ 1,985.29 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
Electrophysiology catheters are mainly associated with cardiac ablation procedures. These procedures have been proposed to improve outcomes among patients suffering from heart failure/cardiac arrhythmia or receiving appropriate treatment, as they are associated with a significantly lower hospitalization and death rate and proven to be the right medical therapy for atrial fibrillation. The increasing number of cardiac catheterization facilities is aiding the Europe electrophysiology catheters market. Such availability of cardiac services promotes the use of catheterization procedures irrespective of clinical indications. This has resulted in significant role in patient management, which is further anticipated to drive the market in Europe.
The COVID-19 pandemic has adversely affected the medical device business in Europe. In 2020, many enterprises suspended their operations due to being unable to meet the high demands. The future medical device regulation (2017/745) of the European Union pushed new norms and recommendations from May 2020 to May 2021. Furthermore, the lowered production of these medical equipment and personal protection equipment has resulted in the insufficient availability of crucial equipment and consumables. The dependence on foreign suppliers has resulted in a lengthy delivery procedure for medical devices and consumables. Patients with atrial fibrillation may have a worsened prognosis when infected with the SARS-CoV-2 virus. According to a study published in the Journal of Cardiovascular Pharmacology in 2020, pharmacokinetic interactions between drugs and experimental therapies used to treat atrial fibrillation and COVID-19, respectively, have resulted in limited use in clinical practice. These drug interactions cause electrocardiographic abnormalities such as extreme bradycardia and QRS widening, thereby underlining the requirement of careful elective management.
Europe Electrophysiology Catheter Market Revenue and Forecast to 2028 (US$ Million)
Europe Electrophysiology Catheter Market Segmentation
Europe Electrophysiology Catheter Market – By Product Type
-
Electrophysiology Ablation Catheters
- Cryoablation Electrophysiology Catheter
- Radiofrequency Ablation Catheters
- Microwave Ablation Systems
- Laser Ablation Systems
-
Electrophysiology Diagnostic Catheters
- Conventional Electrophysiology Diagnostic Catheters
- Advanced Electrophysiology Diagnostic Catheters
- Ultrasound Electrophysiology Diagnostic Catheters
Europe Electrophysiology Catheter Market – By Application
- Diagnosis and Monitoring
- Treatment of Cardiac Arrhythmias
- Imaging and Mapping
Europe Electrophysiology Catheter Market – By End User
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Labs
Europe Electrophysiology Catheter Market– By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Abbott
- APT Medical Inc.
- Biosense Webster (Johnson and Johnson Services, Inc.)
- Biotronik, Inc.
- Boston Scientific Corporation
- Medtronic
- MicroPort Scientific Corporation
- Stryker Corporation
- Transonic Systems Inc.
Europe Electrophysiology Catheter Market Strategic Insights
Europe Electrophysiology Catheter Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 1,141.71 Million |
| Market Size by 2028 | US$ 1,985.29 Million |
| CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Electrophysiology Catheter Market Country and Regional Insights
